Image

White Cover and Massage Impact on Bilirubin Levels and Phototherapy Duration in Newborns

Recruiting
12 - 1 years of age
Both
Phase N/A

Powered by AI

Overview

This study aimed to examine the effect of white cover and massage application on newborns' bilirubin level and duration of phototherapy in newborns receiving phototherapy.

Description

Hyperbilirubinemia is a common problem seen in the neonatal period, characterized by yellow staining of the skin and sclera, causing an increase in total serum bilirubin >5 mg/dl. Neonatal jaundice is seen in 60% of term newborns and 80% of preterm newborns. Hyperbilirubinemia is usually physiological and disappears within a few days. Jaundice may worsen and lead to kernicterus (accumulation of bilirubin in some parts of the brain) or death if pathological hyperbilirubinemia occurs. Therefore, every baby with hyperbilirubinemia and high serum bilirubin levels requires serious attention and treatment. The primary treatment for neonatal jaundice is phototherapy. The effectiveness of phototherapy depends on the phototherapy light source, light intensity, distance between the phototherapy light and the newborn, and the body surface area exposed to the light. Phototherapy has potential side effects in newborns such as hyperthermia, dehydration, diarrhea, bronze baby syndrome, and skin burns. For this reason, the use of phototherapy should be minimized and solutions should be found to shorten the duration of phototherapy. To increase the effectiveness of phototherapy treatment, a reflector material can be added to the phototherapy. White fabric, which can be used as a reflector, can reflect scattered phototherapy light. When fabrics made of reflective materials are hung over the phototherapy device, they can capture the light that may scatter from the baby to the environment and reflect the light back to the baby. White fabric may increase irradiance and therefore lead to increased bilirubin conversion.Studies have reported that massage applied before phototherapy is effective in reducing the bilirubin level in babies with hyperbilirubinemia. Bilirubin is eliminated from the body through defecation. Removing bilirubin from the body reduces jaundice. Massage reduces bilirubin levels by increasing the frequency of bowel movements in newborn babies.

Eligibility

Inclusion Criteria:

  • Term babies with gestational age between 37-42 weeks,
  • Does not have a respiratory, cardiovascular, gastrointestinal or neurological disorder or syndrome that would prevent or complicate oral feeding,
  • Birth weight of 2500 g and above,
  • With phototherapy indication,
  • Do not have any health problems other than neonatal jaundice detected in the prenatal period,
  • Those with a stable health condition,
  • Orally fed,
  • No clinical signs of dehydration,
  • Do not have any skin problems that would prevent baby massage,
  • Newborns with written and verbal informed consent from their families will be included in the study.

Exclusion Criteria:

  • Premature,
  • Those with congenital malformations,
  • Those with hyperbilirubinemia requiring exchange transfusion,
  • Those with Rh hemolytic disease,
  • Having a positive culture test (sepsis),
  • Those with glucose-6-phosphate dehydrogenase (G6PD) deficiency,
  • Birth weight below 2500 grams,
  • Those who were referred to another center during the research,
  • Discharged early,
  • Unexpected complications developed during the research,
  • Bronze child syndrome occurs during phototherapy,
  • Newborns who develop a pathology that will prevent or complicate oral feeding will not be included in the study.

Study details

Newborn Jaundice, Hyperbilirubinemia, Neonatal, Newborn Massage, Phototerapy

NCT06209489

Karabuk University

2 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.